Please assess the completion status of the following clinical trial:

Trial Title: A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Women diagnosed with tubal infertility, unexplained infertility, infertility related to endometriosis stage I/II or with partners diagnosed with male factor infertility~* Women eligible for IVF (in-vitro fertilisation) and/or ICSI (intracytoplasmic sperm injection) treatment~* Women aged 18-37 years~* Women with body mass index (BMI) of 18.5-32.0 kg/m2~Exclusion Criteria:~* Women with polycystic ovary syndrome (PCOS) associated with anovulation, endometriosis stage III/IV~* Women with history of recurrent miscarriage~* Women with contraindications to controlled ovarian stimulation with gonadotropins~* Women with three or more controlled ovarian stimulation cycles

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- 5.2 µg (Type: EXPERIMENTAL): None
- 6.9 µg (Type: EXPERIMENTAL): None
- 8.6 µg (Type: EXPERIMENTAL): None
- 10.3 µg (Type: EXPERIMENTAL): None
- 12.1 µg (Type: EXPERIMENTAL): None
- 11 µg FbM (150 IU) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).